MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.radonc.2025.111092

Медицинская библиотека · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025

Does omitting the clinical target volume in stereotactic radiotherapy for NSCLC affect oncologic outcomes? A retrospective analysis.

Reinhardt Philipp, Kotov Ilya, Schmidhalter Daniel, Correia Dora, Elicin Olgun, Schanne Daniel Hendrik

СтатьяОбзорПеревод пока не подготовлен

Аннотация

AIMS: The use of CTV margins in lung SBRT is not standard practice due to historically high local control (LC) rates and concerns about toxicity. However, limited data exist evaluating their necessity. This study aims to assess LC outcomes in lung SBRT and investigates the relationship between LC and dose coverage for a hypothetical CTV (hCTV).

METHODS

A retrospective analysis was performed on 126 patients with 140 pulmonary lesions, including histopathologically confirmed (46 %) and clinically diagnosed (54 %) lung cancers. Patients treated with a prescribed BED < 100 Gy to the PTV were excluded. hCTVs were defined using 6 mm margins for squamous cell carcinoma and 8 mm margins for adenocarcinoma or clinically diagnosed lesions, which were further expanded into hypothetical planning target volumes. A ring structure (rCTV) was created by subtracting the GTV from the hCTV. Dose-volume histogram parameters were analyzed, and multivariable analysis assessed their relationship with LC.

RESULTS

SBRT was delivered with a median BEDα/β: 10 Gy of 124 Gy prescribed to the PTV (range: 100 Gy-151 Gy). The 3-year LC rates were 83.3 %, 80.5 %, 66.9 %, and 71.0 % for lesions measuring ≤10 mm, 11-20 mm, 21-30 mm, and ≥31 mm, respectively. A significant association was identified between the percentage of rCTV receiving BED ≥100 Gy and LC (HR 0.98; P = 0.044).

CONCLUSIONS

Omitting CTV margins in lung-SBRT may compromise LC when rCTV coverage with BED ≥100 Gy is insufficient, warranting further investigation into the clinical benefit of adding CTV margins.

Для цитирования: Reinhardt Philipp, Kotov Ilya, Schmidhalter Daniel, Correia Dora, Elicin Olgun, Schanne Daniel Hendrik. Does omitting the clinical target volume in stereotactic radiotherapy for NSCLC affect oncologic outcomes? A retrospective analysis.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2025. DOI: 10.1016/j.radonc.2025.111092.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.